We found recurrent glioma patients with R132H-mutated DNA of the gene isocytrate dehydrogenase 1 (IDH1) and patients without chromosome 1p/19q co-deletion were most likely sensitive to Notch inhibitors. The gene discussed is IDH1; the disease is glioma.